fluorodeoxyglucose f18 has been researched along with Mycetoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amazzough, K; Arvieux, C; Barete, S; Bougnoux, ME; Crabol, Y; Lanternier, F; Lecuit, M; Lortholary, O; Maunoury, C; Pineau, S; Poiree, S; Zeller, V | 1 |
Lortholary, O | 1 |
Besson, FL; Blanc-Durand, P; Durand, E; Grimon, G; Meyer, C | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Mycetoma
Article | Year |
---|---|
Last generation triazoles for imported eumycetoma in eleven consecutive adults.
Topics: Adolescent; Adult; Antifungal Agents; beta-Glucans; Child; Exophiala; Fluorodeoxyglucose F18; Fusarium; Humans; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Positron-Emission Tomography; Proteoglycans; Retrospective Studies; Skin; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
[Visceral mycoses].
Topics: Fluorodeoxyglucose F18; Foot Diseases; France; Humans; Immunocompromised Host; Mycetoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Urban Population | 2015 |
PET/CT and MRI Imaging of a Eumycetoma of the Right Thigh.
Topics: Femur; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Mycetoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Thigh | 2017 |